U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940569) titled 'Glutamine Early Start in Children With SCD Younger Than Five' on Nov. 10.

Brief Summary: A study to assess the efficacy and safety of Glutamine in preventing Vaso Occlusive Crisis in pediatric population less than five years old

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Sickle Cell Disease (SCD)

Intervention: DRUG: Glutamine

L-Glutamine as an oral powder

OTHER: Standard of Care (SOC)

Standard of care in SCD therapy as Hydroxyurea

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ain Shams University

Information provided by (Responsible Party): Fatma Soliman Elsayed Ebeid, MD, Ain Shams University

Pub...